Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

Renal cell carcinoma is the most common form of kidney cancer. It can take time to fully process a diagnosis and what, ...

Renal cell carcinoma highlights from ASCO GU 2025 include follow-up data from the CheckMate 9ER study, updated COSMIC-313 results, and promising early data on casdatifan, a new HIF-2 alpha inhibitor.

点击蓝字关注我们【导读】阿西替尼耐药仍然是晚期肾细胞癌（RCC）治疗中的一个严峻挑战，其潜在机制尚未完全明了。2025年2月23日，苏州大学第三附属医院的研究团队在期刊《Cell Death Discovery》上发表了题为“STX17-DT ...

What Is Renal Cell Carcinoma? It's the most common type of kidney cancer. Although it’s a serious disease, finding and treating it early makes it more likely that you’ll be cured. No matter ...

When renal cell cancer is “metastatic,” that means it has spread from your kidney to other parts of your body. Bones are a common place for this cancer to travel. It's harder to treat the ...

A longstanding scientific belief about a link between cancer prevalence and animal body size has been tested for the first ...

A study identified a link between sex hormones and renal cell carcinoma, suggesting potential new treatment strategies.

A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...

Forget one-size-fits-all cancer treatments — personalization is the future, and it’s already showing promise. In a ...